Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (771-780 of 1,132) with videos related to

Pageof 114
Sort By:
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
AIDS (London, England)|June 1, 1994
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study GroupA N Phillips, F Antunes, G Stergious, et al.
HIV Medicine|December 17, 2009
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppressionV Cambiano, F C Lampe, A J Rodger, et al.
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
AIDS (London, England)|December 13, 2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort studyGail V Matthews, Caroline A Sabin, Sundhiya Mandalia, et al.
AIDS (London, England)|February 19, 2005
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimenChristian Holkmann Olsen, Jose Gatell, Bruno Ledergerber, et al.
Proteins|July 16, 2008
Discovery of sarcosine dimethylglycine methyltransferase from Galdieria sulphurariaJason G McCoy, Lucas J Bailey, Yi Han Ng, et al.
Pageof 114

Showing results (771-780 of 1,132) with videos related to

Sort By:
Pageof 114
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
AIDS (London, England)|June 1, 1994
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study GroupA N Phillips, F Antunes, G Stergious, et al.
HIV Medicine|December 17, 2009
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppressionV Cambiano, F C Lampe, A J Rodger, et al.
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
AIDS (London, England)|September 13, 2000
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV MedicineA Mocroft, H Devereux, S Kinloch-de-Loes, et al.
AIDS (London, England)|December 13, 2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort studyGail V Matthews, Caroline A Sabin, Sundhiya Mandalia, et al.
AIDS (London, England)|February 19, 2005
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimenChristian Holkmann Olsen, Jose Gatell, Bruno Ledergerber, et al.
Proteins|July 16, 2008
Discovery of sarcosine dimethylglycine methyltransferase from Galdieria sulphurariaJason G McCoy, Lucas J Bailey, Yi Han Ng, et al.
Pageof 114